Surface Oncology Inc (NASDAQ:SURF)
| 0.62 BATS BZX Real-Time Price As of 11:10am ET |  -0.005 / -0.80%Today’s Change | 0.60 Today|||52-Week Range 3.17 | -24.39% Year-to-Date |
Latest SURF News | Press Releases
| Walgreens (WBA) to Report Q2 Earnings: What's in the Cards? Mar 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.63 |
| Today’s open | 0.61 |
| Day’s range | 0.61 - 0.64 |
| Volume | 983 |
| Average volume (3 months) | 262,175 |
| Market cap | $42.5M |
Data as of 11:10am ET, 03/29/2023
Growth & Valuation
| Earnings growth (last year) | +35.72% |
| Earnings growth (this year) | -15.57% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,016.49% |
| P/E ratio | NM |
| Price/Sales | 1.52 |
| Price/Book | 0.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PLURPluri Inc | 0.00 | 0.00% |
| BCDABioCardia Inc | +0.06 | +2.63% |
| MDNAMedicenna Therapeuti... | -0.03 | -4.89% |
| LPTXLeap Therapeutics In... | +0.01 | +3.12% |
Data as of 11:43am ET, 03/29/2023
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $30.0M |
| Annual profit (last year) | -$63.6M |
| Net profit margin | -211.95% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
